News
Insights into biology, protein structure, ... Kai Y, et al. Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells.
Hosted on MSN6mon
Could a pill replace gene therapy for sickle cell disease ... - MSNDestabilizing BCL11A. In the new work, Orkin and his colleagues explored the structure and chemistry of the BCL11A protein, looking for ways to hit it.
More information: Kazuki Okuyama et al, A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development, Nature Immunology (2024). DOI: 10.1038/s41590 ...
In a form of sickle cell disease called sickle cell anemia, mutations in a gene called HBB affect the protein’s structure, ... Cas9 deactivates BCL11A in bone marrow stem cells, ...
BCL11A: Evidence for neuroprotective effect Date: September 14, 2021 Source: University of Bonn Summary: The neurotransmitter dopamine influences the activity of a wide variety of brain areas.
Darren W. Logan et al. BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription. American Journal of Human Genetics , July 2016 DOI: 10.1016/j.ajhg.2016. ...
Moreover, BCL11A deletion in a mouse model substantially decreased tumor formation, ... "For this study, we stained almost 400 samples out of 2000 for BCL11A protein expression.
The researchers suspect that BCL11A plays a protective role for neurons. The study is now published in Cell Reports. ... a dark-appearing structure in the midbrain, die off.
A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development. Nature Immunology 25 , 2284–2296 (2024). doi: 10.1038/s41590-024-01997-5 Top ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results